UK Parliament / Open data

Breast Cancer Drugs

Proceeding contribution from Norman Lamb (Liberal Democrat) in the House of Commons on Thursday, 26 January 2017. It occurred during Backbench debate on Breast Cancer Drugs.

I congratulate the hon. Lady on securing this important debate. Does she share my concern at news that the Government appear to be ready to leave the European Medicines

Agency following the Brexit vote? Many people fear that that will lead to a slow-down in access to new medicines. She talks about the importance of NHS patients getting access to medicines; this could make the situation worse and leave us disadvantaged compared with other countries in Europe.

Type
Proceeding contribution
Reference
620 c504 
Session
2016-17
Chamber / Committee
House of Commons chamber
Back to top